News & Blog

Scrutiny in Telehealth Space Continues – Recent Investigations and Indictments Suggest Increased Enforcement in the Prescription Medication Space

Recent investigations and arrests targeting telehealth companies, providing virtual treatment for Attention Deficit Hyperactivity Disorder (ADHD)...

New Initiative to Educate Consumers Against Crypto Scams

Introduction As cryptocurrencies continue to integrate into mainstream finance, the ecosystem has seen a rise in sophisticated scams, prompting...

Navigating FCA Compliance and Enforcement: Key False Claims Act Trends for 2024

On May 13, 2024, the U.S. Department of Justice (DOJ) issued a press release touting its 2023 False Claims Act (FCA) “accomplishments” – amassing...

DOJ Proposes Reclassifying Marijuana as Schedule III Controlled Substance

On May 16, 2024, the US Department of Justice (DOJ) officially took steps to reclassify marijuana as a Schedule III controlled substance. This...

The Risks of Relying on Medical Marketing Companies

On April 4, 2024, an indictment was filed in the Tampa Division of the Middle District of Florida (Case 8:24-cr-00156-TPB-NHA) which illustrates the...

Why the Middle District of Florida Should Reconsider its Ban on Electronic Juror Research

Evaluating the Impact of Digital Age Restrictions on Jury Impartiality If the cornerstone of our legal system is the pursuit of justice through the...

DOJ’s New Pilot Program: Voluntary Self-Disclosure for Individuals

Understanding the Department of Justice's New Self-Disclosure Pilot Program On April 15, 2024, the Department of Justice's Criminal Division...

Terraform Labs Case: Key Takeaways for the Crypto Industry

On April 5, 2024, a federal jury in Manhattan returned a verdict finding Terraform Labs and its co-founder, Do Kwon, liable for fraud. In this post,...